rxstat › Drug prices › Eltrombopag

Eltrombopag price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Eltrombopag 25 mg tablet costs about $48.75 to $67.31 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

Eltrombopag has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABSKONNSNL
25 mg Tabletper tablet$63.70not covered$48.75$55.25$48.75$67.31
50 mg Tabletper tablet$127.40not covered$97.50$110.50$97.50$134.62
Plan coverageNot coveredSpecial approvalCoveredSpecial approvalPrice list

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 4 products
  • Apo-Eltrombopag 25 mg Tablet · APX
    DIN 02506742 · $63.70/tablet · Not covered
  • Revolade 25 mg Tablet · NOV
    DIN 02361825 · $65.00/tablet · Not covered
  • Apo-Eltrombopag 50 mg Tablet · APX
    DIN 02506769 · $127.40/tablet · Not covered
  • Revolade 50 mg Tablet · NOV
    DIN 02361833 · $130.00/tablet · Not covered
Saskatchewan: 4 products
  • Apo-Eltrombopag 25 mg Tablet · APX
    DIN 02506742 · $48.75/tablet · Special approval
  • Revolade 25 mg Tablet · NVR
    DIN 02361825 · $65.00/tablet · Special approval
  • Apo-Eltrombopag 50 mg Tablet · APX
    DIN 02506769 · $97.50/tablet · Special approval
  • Revolade 50 mg Tablet · NVR
    DIN 02361833 · $130.00/tablet · Special approval
Ontario: 4 products
  • Apo-Eltrombopag 25 mg Tablet · Apotex Inc.
    DIN 02506742 · $55.25/tablet · Covered
  • Revolade 25 mg Tablet · GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
    DIN 02361825 · $65.00/tablet · Covered
  • Apo-Eltrombopag 50 mg Tablet · Apotex Inc.
    DIN 02506769 · $110.50/tablet · Covered
  • Revolade 50 mg Tablet · GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
    DIN 02361833 · $130.00/tablet · Covered
Nova Scotia: 4 products
  • Revolade 25 mg Tablet · NVR
    DIN 02361825 · $48.75/tablet · Special approval
  • Apo-Eltrombopag 25 mg Tablet · APX
    DIN 02506742 · $48.75/tablet · Special approval
  • Revolade 50 mg Tablet · NVR
    DIN 02361833 · $97.50/tablet · Special approval
  • Apo-Eltrombopag 50 mg Tablet · APX
    DIN 02506769 · $97.50/tablet · Special approval
Newfoundland and Labrador: 4 products
  • Apo-Eltrombopag 25 mg Tablet · APX
    DIN 02506742 · $67.31/tablet · Price list
  • Revolade 25 mg Tablet · NVR
    DIN 02361825 · $70.85/tablet · Price list
  • Apo-Eltrombopag 50 mg Tablet · APX
    DIN 02506769 · $134.62/tablet · Price list
  • Revolade 50 mg Tablet · NVR
    DIN 02361833 · $141.70/tablet · Price list

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026) · Newfoundland and Labrador Interchangeable Drug Products Formulary (Oct 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
1

Shortage history

2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

Resolved
APO-ELTROMBOPAG
50MG · TABLET · APOTEX INC
DIN 02506769 · ended Apr 4, 2024 · Disruption of the manufacture of the drug.

What's happening

There are no active shortage reports for Eltrombopag.

Eltrombopag is classified under “VITAMIN K AND OTHER HEMOSTATICS” (ATC B02BX).

Recent changes

Common questions

How much does Eltrombopag cost in Canada?

Eltrombopag 25 mg tablet costs about $48.75 to $67.31 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

Is Eltrombopag covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered; Saskatchewan: special approval; Ontario: covered; Nova Scotia: special approval; Newfoundland and Labrador: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Eltrombopag be back in stock in Canada?

Eltrombopag has no active shortage; supply is normal per Health Canada reports.

Why is Eltrombopag in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (vitamin k and other hemostatics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.